293 related articles for article (PubMed ID: 29057449)
21. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Kheiri B; Barbarawi M; Zayed Y; Hicks M; Osman M; Rashdan L; Kyi HH; Bachuwa G; Hassan M; Stecker EC; Nazer B; Bhatt DL
Circ Arrhythm Electrophysiol; 2019 Nov; 12(11):e007600. PubMed ID: 31698933
[TBL] [Abstract][Full Text] [Related]
22. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
[TBL] [Abstract][Full Text] [Related]
25. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
27. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.
Credner SC; Klingenheben T; Mauss O; Sticherling C; Hohnloser SH
J Am Coll Cardiol; 1998 Dec; 32(7):1909-15. PubMed ID: 9857871
[TBL] [Abstract][Full Text] [Related]
28. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias.
Otuki S; Hasegawa K; Watanabe H; Katsuumi G; Yagihara N; Iijima K; Sato A; Izumi D; Furushima H; Chinushi M; Aizawa Y; Minamino T
J Electrocardiol; 2017; 50(3):277-281. PubMed ID: 28238302
[TBL] [Abstract][Full Text] [Related]
29. Electrical storm in a middle-aged man.
Ahadzi D; Agyekum F; Doku A; Yakubu AS; Hoedofia G; Ayetey H
Ghana Med J; 2023 Jun; 57(2):156-160. PubMed ID: 38504757
[TBL] [Abstract][Full Text] [Related]
30. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
31. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
[TBL] [Abstract][Full Text] [Related]
32. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
[TBL] [Abstract][Full Text] [Related]
34. Oral mexiletine for ventricular tachyarrhythmias treatment in implantable cardioverter-defibrillator patients: a systematic review of the literature.
Ali H; Cristiano E; Lupo P; Foresti S; DE Ambroggi G; DE Lucia C; Turturiello D; Paganini EM; Bessi R; Farghaly AA; Nicolì L; Cappato R
Minerva Cardiol Angiol; 2023 Dec; 71(6):622-630. PubMed ID: 36305779
[TBL] [Abstract][Full Text] [Related]
35. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
36. Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design.
Kurita T; Mitamura H; Aizawa Y; Nitta T; Aonuma K; Tsuboi N; Chinushi M; Kobayashi Y; Soejima K; Satomi K; Furushima H; Ohe T; Ogawa S; Kodama I; Ohtsu H; Yamazaki T;
Circ J; 2006 Mar; 70(3):316-20. PubMed ID: 16501299
[TBL] [Abstract][Full Text] [Related]
37. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.
Manuchehry A; Agusala K; Montevecchi M; Kadish A; Passman R
Pacing Clin Electrophysiol; 2011 May; 34(5):571-6. PubMed ID: 21208242
[TBL] [Abstract][Full Text] [Related]
38. Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients.
Weidner K; Behnes M; Weiß C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Schupp T; Kim SH; Barth C; Hoppner J; Akin M; Mashayekhi K; Borggrefe M; Akin I
Heart Vessels; 2019 Nov; 34(11):1811-1822. PubMed ID: 31076852
[TBL] [Abstract][Full Text] [Related]
39. Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator.
Alzand BS; Timmermans CC; Wellens HJ; Dennert R; Philippens SA; Portegijs PJ; Rodriguez LM
J Interv Card Electrophysiol; 2011 Aug; 31(2):149-56. PubMed ID: 21340515
[TBL] [Abstract][Full Text] [Related]
40. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
Gojkovic O; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Singh BN; Kowey PR
Heart Rhythm; 2012 Feb; 9(2):217-224.e2. PubMed ID: 21978965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
